I6T-MC-AMBG
| abstract | A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients with Moderately to Severely Active Ulcerative Colitis LUCENT 2 |
| type of project | clinical studies |
| status | ongoing - recruiting phase |
| start of project | 2018 |
| end of project | 2021 |
| responsible person | Prof. Dr. Stephan Brand |